Short-chain fatty acids in nonalcoholic fatty liver disease: New prospects for short-chain fatty acids as therapeutic targets
Xinyu Li(Shanghai Jiao Tong University), Yaling Zhu(Anhui Medical University), Meizi Zhu(Anhui Medical University), Min Xue(California Institute of Technology), Xuejin Lu(Anhui Medical University), Xinrui Yi(Anhui Medical University), Yunshu Tang(Anhui Medical University), Maozhang He(Anhui Medical University)
Cited by 68
Related Papers
Myricetin supplementation decreases hepatic lipid synthesis and inflammation by modulating gut microbiota
|Cell Reports|2021|120
MicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease
|World Journal of Gastroenterology|2014|59
Anti-inflammatory effect of luteolin is related to the changes in the gut microbiota and contributes to preventing the progression from simple steatosis to nonalcoholic steatohepatitis
|Bioorganic Chemistry|2021|54
Bidirectional and persistent immunomodulation of Astragalus polysaccharide as an adjuvant of influenza and recombinant SARS-CoV-2 vaccine
|International Journal of Biological Macromolecules|2023|47
Modes of genetic adaptations underlying functional innovations in the rumen
|Science China Life Sciences|2020|41